The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients-Reference-Cited by-同舟云学术

The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients

Published:2019-04-05 Issue:18 Volume:76 Page:3641-3656
ISSN:1420-682X
Container-title:Cellular and Molecular Life Sciences
language:en
Short-container-title:Cell. Mol. Life Sci.

Author:

Szpechcinski Adam^ORCID,Florczuk Mateusz,Duk Katarzyna,Zdral Aneta,Rudzinski Stefan,Bryl Maciej,Czyzewicz Grzegorz,Rudzinski Piotr,Kupis Wlodzimierz,Wojda Emil,Giedronowicz Dorota,Langfort Renata,Barinow-Wojewodzki Aleksander,Orlowski Tadeusz,Chorostowska‐Wynimko Joanna

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Cellular and Molecular Neuroscience,Pharmacology,Molecular Biology,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00018-019-03089-2.pdf

Reference76 articles.

1. Castellanos E, Feld E, Horn L (2017) Driven by mutations: the predictive value of mutation subtype in EGFR-mutated non-small cell lung cancer. J Thorac Oncol 12:612–623

2. Singh M, Jadhav HR (2018) Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors. Drug Discov Today 23:745–753

3. Lee DH (2017) Treatments for EGFR-mutant non-small cell lung cancer (NSCLC): the road to a success, paved with failures. Pharmacol Ther 174:1–21

4. Chorostowska-Wynimko J, Szpechcinski A (2007) The impact of genetic markers on the diagnosis of lung cancer: a current perspective. J Thorac Oncol 2:1044–1051

5. Han X et al (2014) Suitability of surgical tumor tissues, biopsy, or cytology samples for epidermal growth factor receptor mutation testing in non-small cell lung carcinoma based on chinese population. Transl Oncol 7:795–799

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating miR-28-5p is overexpressed in patients with sarcopenia despite long-term remission of Cushing’s syndrome: a pilot study;Frontiers in Endocrinology;2024-07-17

2. The Effect of Hsa-miR-504 Targeting MUC16 in Ovarian Cancer Progression;Journal of Biomedical Nanotechnology;2024-07-01

3. The interaction of mast cells with membranes from lung cancer cells induces the release of extracellular vesicles with a unique miRNA signature;Scientific Reports;2023-12-06

4. Circulating noncoding RNAs: promising biomarkers in liquid biopsy for the diagnosis, prognosis, and therapy of NSCLC;Discover Oncology;2023-08-01

5. Circulating miRNAs and their functional genetic variants in pseudoexfoliative glaucoma: potential of miR-146a-5p as a diagnostic biomarker;International Ophthalmology;2023-07-07